Zydus gets Phase III nod from DCGI for Zintrodiazine in malaria, targets drug resistance challenge
Key Highlights: Implications: Zintrodiazine’s Phase...
Key Highlights: Implications: Zintrodiazine’s Phase...
Key Highlights: Implications: Zydus is differentiating in a crowded...
Key Highlights: Implications: Aerolife Mini strengthens...
Key Highlights: Implications: Aerolife Mini strengthens...
Key Highlights: Implications: The partnership lets Zydus scale its...
Key Highlights: Implications: The deal lets Lupin plug...